HER-2 positive breast cancer comprises cancers which exhibit the overexpression or amplification of the Erb-B2 Receptor Tyrosine Kinase 2 (ERBB2) gene (also known as the HER2 protein) and accounts for approximately 20% of all breast cancers. Here, ERBB2 is linked to breast cancer.